CUSIP: 816212104
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
50,616,370
-
Share change
-
-6,122,388
-
Total reported value
-
$153,383,148
-
Put/Call ratio
-
592%
-
Price per share
-
$3.03
-
Number of holders
-
89
-
Value change
-
-$14,400,142
-
Number of buys
-
55
-
Number of sells
-
28
Quarterly Holders Quick Answers
What is CUSIP 816212104?
CUSIP 816212104 identifies RNAC - SELECTA BIOSCIENCES INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2021
-
Previous quarter:
Q3 2020
Recent filing periods for CUSIP 816212104:
Institutional Holders of SELECTA BIOSCIENCES INC - COM (RNAC) as of Q4 2020
As of 31 Dec 2020,
SELECTA BIOSCIENCES INC - COM (RNAC) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,616,370 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Artal Group S.A., BVF INC/IL, BOXER CAPITAL, LLC, Marshall Wace North America L.P., Polaris Venture Management Co. V, L.L.C., TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, and ARMISTICE CAPITAL, LLC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.